Elanco Animal Health Incorporated (ELAN) — Fair Value Analysis
Base-case fair value (P50): $22.16 · Current price: $26.39 · Verdict: Overvalued
The Verdict on ELAN
ELANCO ANIMAL HEALTH INC (ELAN) is currently assessed as Fairly Valued according to our Monte Carlo simulations. With ELAN trading at $26.39, our median fair value (P50) stands at $22.16. This indicates a projected -16.0%, suggesting the current market price is largely aligned with fundamental expectations derived from thousands of forward-looking scenarios. While some investors might seek more significant upside, ELAN's current valuation, relative to its intrinsic fair value, does not signal a pronounced over or undervaluation based on our models.
How ELAN stacks up against peers
ELAN's operational and financial health is currently categorized as average when compared to its broader sector. This "average" quality tier means that while ELAN is not a top-tier performer, it also doesn't present significant immediate red flags in its underlying business fundamentals. The stock's current price of $26.39 and its median fair value of $22.16 reflect this balanced fundamental assessment. An average quality tier suggests that the market's current valuation, reflected in the -16.0% difference, is largely rationalized by its competitive standing and financial stability.
What this means for investors
For investors considering ELAN, the verdict of Fairly Valued and the -16.0% difference between the $26.39 and $22.16 imply a limited immediate arbitrage opportunity based purely on intrinsic valuation. While ELAN's average quality tier indicates a stable underlying business, significant outperformance or underperformance would likely hinge on catalysts beyond its current intrinsic value. Our Monte Carlo simulations, which generate the median fair value of $22.16, encapsulate a wide range of potential outcomes. For a deeper understanding of ELAN's full bear and bull case distribution and to track its fair value as new fundamentals are released, sign up for FairCurve today.
Frequently Asked Questions
Is ELAN overvalued or undervalued right now?
Based on our Monte Carlo simulations, ELAN is currently assessed as Fairly Valued. With a current price of $26.39 against a median fair value of $22.16, the stock shows neither significant overvaluation nor undervaluation.
What is the bear case and bull case for ELAN?
Our full Monte Carlo distribution, including bear (P10) and bull (P90) price targets, as well as the probability of achieving upside scenarios, is available to subscribers who sign up for a free FairCurve account. We do not provide specific dollar values for these scenarios publicly.
How does FairCurve calculate ELAN's fair value?
FairCurve calculates ELAN's fair value using sophisticated Monte Carlo simulations, running thousands of forward-looking scenarios to determine the most probable intrinsic value. This robust methodology incorporates various financial drivers and market conditions to project a comprehensive valuation.
How can I track ELAN's fair value as it changes?
You can add ELAN to your free FairCurve watchlist to receive daily updates on its fair value. FairCurve also provides instant re-valuation of ELAN's intrinsic worth whenever new earnings or significant fundamental data are released.